-
-
-
-
-
-
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
-
-
-
-
-
-
Repligen to Report Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Benchmark Reiterates Hold Rating on Repligen (RGEN)
-
-
-
-
-
-
-
Repligen to Report Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Deutsche Bank Upgrades Repligen (RGEN) to Buy
-
-
-
-
-
-
-
Repligen to Report Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Repligen (RGEN) to Acquire Fluid Management Innovator Metenova
-
1,198,889 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

